- Home
- AVPT vs RGC Comparison
AVPT vs RGC Comparison
Compare AVPT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVPT | RGC |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | Hong Kong |
| Employees | 3443 | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | AVPT | RGC |
|---|---|---|
| Price | $14.27 | $9.73 |
| Analyst Decision | Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $16.81 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 221.5K |
| Earning Date | 11-05-2026 | 10-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $21.81 | N/A |
| Revenue Next Year | $20.37 | N/A |
| P/E Ratio | $1,348.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.84 | $4.51 |
| 52 Week High | $15.43 | $69.00 |
Technical Indicators
Market Signals| Indicator | AVPT | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 78.76 |
| Support Level | $12.36 | $4.97 |
| Resistance Level | $14.39 | $29.26 |
| Average True Range (ATR) | 0.58 | 0.99 |
| MACD | 0.01 | 0.29 |
| Stochastic Oscillator | 46.35 | 75.30 |
Price Performance
Historical ComparisonAbout AVPT AvePoint Inc.
AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.